Application Nr Approved Date Route Status External Links
ANDA209180 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1. Indications And Usage Alosetron Hydrochloride Tablets Are Indicated Only For Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome (Ibs) Who Have: Chronic Ibs Symptoms (Generally Lasting 6 Months Or Longer), Had Anatomic Or Biochemical Abnormalities Of The Gastrointestinal Tract Excluded, And Not Responded Adequately To Conventional Therapy. Diarrhea-Predominant Ibs Is Severe If It Includes Diarrhea And One Or More Of The Following: Frequent And Severe Abdominal Pain/discomfort, Frequent Bowel Urgency Or Fecal Incontinence, Disability Or Restriction Of Daily Activities Due To Ibs. Because Of Infrequent But Serious Gastrointestinal Adverse Reactions Associated With Alosetron Hydrochloride Tablets, The Indication Is Restricted To Those Patients For Whom The Benefit-To-Risk Balance Is Most Favorable. Clinical Studies Have Not Been Performed To Adequately Confirm The Benefits Of Alosetron Hydrochloride Tablets In Men. Alosetron Hydrochloride Tablets Are A Selective Serotonin 5-Ht 3 Antagonist Indicated Only For Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome (Ibs) Who Have: Chronic Ibs Symptoms (Generally Lasting 6 Months Or Longer), Had Anatomic Or Biochemical Abnormalities Of The Gastrointestinal Tract Excluded, And Not Responded Adequately To Conventional Therapy. ( 1 ) Severe Ibs Includes Diarrhea And 1 Or More Of The Following: Frequent And Severe Abdominal Pain/discomfort, Frequent Bowel Urgency Or Fecal Incontinence, Disability Or Restriction Of Daily Activities Due To Ibs. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Alosetron Hydrochloride ALOSETRON HYDROCHLORIDE ZINC13537284

Comments